Wade G W & Inc Gilead Sciences, Inc. Transaction History

Wade G W & Inc

$3.08 Billion
Q4 2023

A detailed history of Wade G W & Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wade G W & Inc holds 11,903 shares of GILD stock, worth $793,811. This represents 0.03% of its overall portfolio holdings.

Number of Shares

11,903

Previous 11,890 0.11%

Holding current value

$793,811

Previous $891,000 8.19%

% of portfolio

0.03%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$73.27 - $83.09 $952 - $1,080	13 Added 0.11%	11,903 $964,000
Q3 2023 Nov 08, 2023	BUY	$73.94 - $80.67 $17,893 - $19,522	242 Added 2.08%	11,890 $891,000
Q2 2023 Aug 10, 2023	SELL	$76.01 - $86.7 $9,805 - $11,184	-129 Reduced 1.1%	11,648 $898,000
Q1 2023 May 09, 2023	SELL	$77.31 - $88.08 $49,169 - $56,018	-636 Reduced 5.12%	11,777 $977,000
Q4 2022 Feb 10, 2023	BUY	$62.32 - $89.47 $747 - $1,073	12 Added 0.1%	12,413 $1.07 Million

Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $1,488 - $1,700	25 Added 0.2%	12,401 $765,000
Q2 2022 Aug 09, 2022	BUY	$57.72 - $65.01 $21,587 - $24,313	374 Added 3.12%	12,376 $765,000
Q1 2022 May 10, 2022	SELL	$57.92 - $72.58 $207,469 - $259,981	-3,582 Reduced 22.99%	12,002 $714,000
Q4 2021 Feb 09, 2022	BUY	$64.88 - $73.64 $22,967 - $26,068	354 Added 2.32%	15,584 $1.13 Million
Q3 2021 Nov 03, 2021	SELL	$67.69 - $73.03 $47,789 - $51,559	-706 Reduced 4.43%	15,230 $1.06 Million
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $227,539 - $248,619	-3,585 Reduced 18.36%	15,936 $1.1 Million
Q1 2021 May 05, 2021	BUY	$60.0 - $68.46 $238,620 - $272,265	3,977 Added 25.59%	19,521 $1.26 Million
Q4 2020 Feb 03, 2021	SELL	$56.65 - $64.55 $30,874 - $35,179	-545 Reduced 3.39%	15,544 $906,000
Q3 2020 Nov 09, 2020	BUY	$62.1 - $78.08 $993 - $1,249	16 Added 0.1%	16,089 $1.02 Million
Q2 2020 Aug 07, 2020	BUY	$72.34 - $84.0 $752,553 - $873,852	10,403 Added 183.47%	16,073 $1.24 Million
Q1 2020 May 06, 2020	SELL	$62.63 - $80.22 $196,846 - $252,131	-3,143 Reduced 35.66%	5,670 $424,000
Q4 2019 Feb 07, 2020	BUY	$61.62 - $67.78 $20,581 - $22,638	334 Added 3.94%	8,813 $573,000
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $687 - $759	-11 Reduced 0.13%	8,479 $537,000
Q2 2019 Aug 12, 2019	SELL	$61.87 - $69.38 $5,258 - $5,897	-85 Reduced 0.99%	8,490 $574,000
Q1 2019 May 09, 2019	BUY	$62.53 - $70.05 $7,253 - $8,125	116 Added 1.37%	8,575 $557,000
Q4 2018 Feb 04, 2019	SELL	$60.54 - $79.0 $55,696 - $72,680	-920 Reduced 9.81%	8,459 $529,000
Q3 2018 Nov 07, 2018	SELL	$71.28 - $78.92 $45,476 - $50,350	-638 Reduced 6.37%	9,379 $724,000
Q1 2018 May 04, 2018	BUY	$72.84 - $88.8 $23,600 - $28,771	324 Added 3.34%	10,017 $755,000
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $3,415 - $4,008	48 Added 0.5%	9,693 $694,000
Q3 2017 Nov 09, 2017	BUY	$72.11 - $85.47 $695,500 - $824,358	9,645	9,645 $781,000

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wade G W & Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wade G W & Inc with notifications on news.

Account